Getting surgery is weird because when you’re in there you have about $100T of collective resourcing and training and technology and medical advancements in the last 400 years contributing to the operation, and then post-op you just have a four page packet that hasn’t changed since 1985 that says to take Tylenol as needed.
Risk vs benefit isn’t worth it.
Aspiration is no joke. Even if you’re young and healthy you’ll be intubated in the ICU for at least 24 hrs while your lungs recover from the inflammation +/- bronch.
Maybe you can get away with naunce for some but that dice is not worth rolling at scale.
@txsportsdoc I don't know of any, but I have started using Wispr Flow to dictate portions of my notes, and that has saved me hours and hours every week.
@DrDiGiorgio@NeilFlochMD As someone in private practice, the problem runs deeper than policy. It's also the pipeline. Physicians coming out of training have no concept of what it would be like to be in private practice and can only imagine being in an employed model. That is the base programming.
@NelsonMogaka_ ??? Surgeons from where? I've heard of this happening in Latin America.
There isn't really a mechanism for this to happen in the US. Most hospitals here are "non-profit" and take public and private. They also own all the surgeons.....
Good post and good comments.
RCT need to be corroborated with independent (not industry) real world data.
More and more it feels like RCTs are more for shareholders than scientists and physicians.
The GLP-1 RCTs leaned into "efficacy estimands" to publish results.... and the Tz RCT moved lilly stock $700B. Those of us in the real world don't see those results in our treatment population.
Agree with a comment that Box and whiskers is the best way to display data in most cases. So much more helpful.